Polycystic Liver Disease

How to Cite This Chapter: Essaji Y, Krawczyk M, Patkowski W. Polycystic Liver Disease. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. https://empendium.com/mcmtextbook/chapter/B31.II.7.30.11.3. Accessed April 21, 2024.
Last Updated: July 11, 2022
Last Reviewed: July 11, 2022
Chapter Information

Polycystic liver disease (PCLD) is characterized by the presence of numerous (>20) hepatic cysts similar in structure to simple cysts, but usually larger. It can occur alone (best prognosis; usually asymptomatic) or coexist with polycystic kidney disease—both with the autosomal dominant form (the most common form of PCLD; see Autosomal Dominant Polycystic Kidney Disease (ADPKD)) and the autosomal recessive form (the least common form).

Treatment should be considered in the case of symptomatic cysts (percutaneous aspiration, surgical aspiration). Benefits of using somatostatin analogues and mTOR inhibitors (eg, sirolimus) have been reported. In patients with severe symptoms and a large number of cysts, liver transplant may be considered, sometimes simultaneously with kidney transplant.

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.